New Delhi: India on Wednesday said that Biological E’s COVID-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country’s other two main shots, Covaxin and AstraZeneca’s Covishield, from August 12 (Friday).
Corbevax will be available to over to those above the age of 18, as a precautionary booster six months after a second dose, the health ministry said in an August 8 letter to state authorities and shared with reporters on Wednesday.
Covishield is produced for the Indian market by the Serum Institute of India under licence from AstraZeneca, while Bharat Biotech makes Covaxin.
India has so far administered more than 2 billion COVID vaccine shots, including 113 million boosters, all of which have so far been of the same vaccine as the recipient’s first two doses. The government says about 89% of Indians above the age of 12 have had two doses.
Puri: The cutting of logs for construction of the three chariots for the annual Rath…
New Delhi: Versatile Bollywood actress Alia Bhatt and Olympic medal-winning wrestler Sakshi Malik have been named…
Kochi: Kerala Police have registered a case against two female foreign tourists for destroying pro-Palestine…
Bhubaneswar: Bharatiya Janata Party (BJP) moved Odisha’s Chief Electoral Officer (CEO) accusing the ruling Biju…
New Delhi: Developing vaccines to prevent fatal diseases can take years. Fortunately, the first vaccine…
Sundargarh: Two participants of a bike rally held on the occasion of Ram Navami were…
Mumbai: Boney Kapoor experienced several ups and downs before establishing himself as a leading producer…
Bhubaneswar: A passenger, who was allegedly smuggling gold, was caught by Customs officials at the…